The burden of sudden cardiac death remains high, accounting for over 350,000 deaths in the US annually. The implantable defibrillator remains the major primary prevention modality. However, in order for this important measure to stay sustainable from a health costs perspective, the criteria for selecting candidates most likely to benefit need to be improved significantly. It will be important to identify all use cases with implantable defibrillators to identify the ones who benefit the most.
Idea No. 158